L P Roy. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Adrenergic beta-Antagonists/adverse effectsAdrenergic beta-Antagonists/therapeutic useAngiotensin-Converting Enzyme Inhibitors/adverse effectsAngiotensin-Converting Enzyme Inhibitors/therapeutic useAntihypertensive Agents/adverse effectsAntihypertensive Agents/therapeutic useChildHumansHypertension/drug therapyVasodilator Agents/adverse effectsVasodilator Agents/therapeutic use
Substances: See more » Adrenergic beta-AntagonistsAngiotensin-Converting Enzyme InhibitorsAntihypertensive AgentsVasodilator Agents
Year: 1988 PMID: 2906330 DOI: 10.1007/BF02810357
Source DB: PubMed Journal: Indian J Pediatr ISSN: 0019-5456 Impact factor: 1.967